NAZOPASS nasal drops 0,5mg/ml 10ml
Nazopass 0.5 mg/ml nasal drops, solution
oxymetazoline hydrochloride /oxymetazoline hydrochloride
Purpose:
Nose drops reducing the swelling of the mucous membranes. For nasal use only. It can be used by adults and children over 6 years old.
Action:
The medicinal product contains the active substance oxymetazoline hydrochloride. This active substance has vasoconstrictor properties and therefore reduces swelling of the mucous membranes. The product can be used by adults and children over 6 years old in the following conditions:
Relieves nasal congestion associated with inflammation of the nasal mucosa (rhinitis): accompanied by a cold (acute rhinitis), such as hay fever (allergic rhinitis), caused by various types of irritants (vasomotor rhinitis), accompanied by inflammation of the lining of the sinuses (sinusitis ), accompanied by inflammation of the Eustachian tube and the middle ear.
Warnings:
Talk to your doctor or pharmacist before using Nasopas if you have any of the following conditions:
- increased intraocular pressure or narrow-angle glaucoma (a type of glaucoma);
- if you have severe cardiovascular disease (such as coronary artery disease);
- if you have high blood pressure;
- if you are being treated with MAO inhibitors or tricyclic antidepressants (medicines to treat depression) or other medicines that can increase blood pressure;
- if you have a tumor of the adrenal gland (called pheochromocytoma);
- if you have metabolic problems such as increased activity of the thyroid gland (hyperthyroidism) or diabetes mellitus;
- if you have an enlarged prostate (prostatic hypertrophy);
- if you have a disease known as porphyria (substances called porphyrins that negatively affect the skin or nervous system).
Long-term use of nasal drops to relieve nasal congestion can cause reactive hyperemia (known as the rebound effect), chronic swelling and eventual atrophy of the nasal mucosa.
In the case of patients with chronic rhinitis, oxymetazoline should only be used intermittently and under medical supervision due to the risk of mucosal atrophy (thinning of the nasal mucosa).
Avoid long-term use and overdose.
Method of use:
1 or 2 drops in each nostril, two to three times daily.
The effect starts within seconds and can last up to 12 hours.
The single dose of the drug should not be used more than three times a day.
Adverse drug reactions:
Possible side effects include:
Common (may affect up to 1 in 10 people): burning sensation or dryness of the nasal mucosa, sneezing.
Uncommon (may affect up to 1 in 100 people): hypersensitivity reactions (redness of the skin, itching, swelling of the skin and mucous membranes) stuffy nose, increased swelling of the nasal mucosa when the medicine becomes ineffective.
Rare (may affect up to 1 in 1,000 people): palpitations, fast heartbeat (tachycardia), increased blood pressure.
Very rare (may affect up to 1 in 10,000 people): anxiety, disturbed sleep, fatigue (drowsiness, sedation), headache, hallucinations (especially in children) and convulsions (especially in children), cardiac arrhythmias (heart rhythm problems) .
Composition:
Active ingredients - oxymetazoline hydrochloride. 1 ml of solution contains 0.5 mg of oxymetazoline hydrochloride.
Excipients - sodium citrate, citric acid monohydrate, disodium edetate, benzalkonium chloride, glycerol and water for injections.
Special instructions:
Medicinal product without a prescription. Read the leaflet before use. Keep out of the reach of children. To be stored at a temperature below 25°C. Use before expiration date.